Skip to main content

Figure 4.

Figure 4

Cytotoxicity of purified NK and γδ T cells derived from NPC patients with different disease status against tumor targets. Cytotoxicity of purified NK and γδ T cells against NPC targets was determined as described in Figure 3, and compared between NPC patients with disease status II (P1), III (P2) and IV (P3).